Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer Journal Article
| Authors: | Shen, H.; Fridley, B. L.; Song, H.; Lawrenson, K.; Cunningham, J. M.; Ramus, S. J.; Cicek, M. S.; Tyrer, J.; Stram, D.; Larson, M. C.; Köbel, M.; Ziogas, A.; Zheng, W.; Yang, H. P.; Wu, A. H.; Wozniak, E. L.; Ling Woo, Y.; Winterhoff, B.; Wik, E.; Whittemore, A. S.; Wentzensen, N.; Palmieri Weber, R.; Vitonis, A. F.; Vincent, D.; Vierkant, R. A.; Vergote, I.; Van den Berg, D.; Van Altena, A. M.; Tworoger, S. S.; Thompson, P. J.; Tessier, D. C.; Terry, K. L.; Teo, S. H.; Templeman, C.; Stram, D. O.; Southey, M. C.; Sieh, W.; Siddiqui, N.; Shvetsov, Y. B.; Shu, X. O.; Shridhar, V.; Wang-Gohrke, S.; Severi, G.; Schwaab, I.; Salvesen, H. B.; Rzepecka, I. K.; Runnebaum, I. B.; Anne Rossing, M.; Rodriguez-Rodriguez, L.; Risch, H. A.; Renner, S. P.; Poole, E. M.; Pike, M. C.; Phelan, C. M.; Pelttari, L. M.; Pejovic, T.; Paul, J.; Orlow, I.; Zawiah Omar, S.; Olson, S. H.; Odunsi, K.; Nickels, S.; Nevanlinna, H.; Ness, R. B.; Narod, S. A.; Nakanishi, T.; Moysich, K. B.; Monteiro, A. N. A.; Moes-Sosnowska, J.; Modugno, F.; Menon, U.; McLaughlin, J. R.; McGuire, V.; Matsuo, K.; Mat Adenan, N. A.; Massuger, L. F. A. G.; Lurie, G.; Lundvall, L.; Lubinski, J.; Lissowska, J.; Levine, D. A.; Leminen, A.; Lee, A. W.; Le, N. D.; Lambrechts, S.; Lambrechts, D.; Kupryjanczyk, J.; Krakstad, C.; Konecny, G. E.; Krüger Kjaer, S.; Kiemeney, L. A.; Kelemen, L. E.; Keeney, G. L.; Karlan, B. Y.; Karevan, R.; Kalli, K. R.; Kajiyama, H.; Ji, B. T.; Jensen, A.; Jakubowska, A.; Iversen, E.; Hosono, S.; Hogdall, C. K.; Hogdall, E.; Hoatlin, M.; Hillemanns, P.; Heitz, F.; Hein, R.; Harter, P.; Halle, M. K.; Hall, P.; Gronwald, J.; Gore, M.; Goodman, M. T.; Giles, G. G.; Gentry-Maharaj, A.; Garcia- Closas, M.; Flanagan, J. M.; Fasching, P. A.; Ekici, A. B.; Edwards, R.; Eccles, D.; Easton, D. F.; Durst, M.; du Bois, A.; Dork, T.; Doherty, J. A.; Despierre, E.; Dansonka-Mieszkowska, A.; Cybulski, C.; Cramer, D. W.; Cook, L. S.; Chen, X.; Charbonneau, B.; Chang-Claude, J.; Campbell, I.; Butzow, R.; Bogdanova, N.; Block, M. S.; Benjamin, E.; Beesley, J.; Beckmann, M. W.; Bandera, E. V.; Baglietto, L.; Bacot, F.; Armasu, S. M.; Antonenkova, N.; Anton-Culver, H.; Aben, K. K.; Liang, D.; Wu, X.; Lu, K.; Hildebrandt, M. A. T.; Australian Ovarian Cancer Study Group; Australian Cancer Study; Schildkraut, J. M.; Seller, T. A.; Huntsman, D.; Berchuck, A.; Chenevix-Trench, G.; Gayther, S. A.; Pharoah, P. D. P.; Laird, P. W.; Goode, E. L.; Pearce, C. L. |
| Article Title: | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
| Abstract: | HNF1B is overexpressed in clear cell epithelial ovarian cancer, and we observed epigenetic silencing in serous epithelial ovarian cancer, leading us to hypothesize that variation in this gene differentially associates with epithelial ovarian cancer risk according to histological subtype. Here we comprehensively map variation in HNF1B with respect to epithelial ovarian cancer risk and analyse DNA methylation and expression profiles across histological subtypes. Different single-nucleotide polymorphisms associate with invasive serous (rs7405776 odds ratio (OR)=1.13, P=3.1 × 10 -10) and clear cell (rs11651755 OR=0.77, P=1.6 × 10 -8) epithelial ovarian cancer. Risk alleles for the serous subtype associate with higher HNF1B-promoter methylation in these tumours. Unmethylated, expressed HNF1B, primarily present in clear cell tumours, coincides with a CpG island methylator phenotype affecting numerous other promoters throughout the genome. Different variants in HNF1B associate with risk of serous and clear cell epithelial ovarian cancer; DNA methylation and expression patterns are also notably distinct between these subtypes. These findings underscore distinct mechanisms driving different epithelial ovarian cancer histological subtypes. © 2013 Macmillan Publishers Limited. All rights reserved. |
| Keywords: | controlled study; promoter region; single nucleotide polymorphism; polymorphism, single nucleotide; histopathology; cancer risk; ovarian neoplasms; phenotype; gene; gene overexpression; genetic predisposition to disease; gene expression profiling; genetic association; genetic variability; gene frequency; dna methylation; risk factor; histology; carcinogenesis; gene mapping; epigenetics; cpg island; epigenesis, genetic; promoter regions, genetic; genetic susceptibility; ovary carcinoma; genome; clear cell carcinoma; hepatocyte nuclear factor 1beta; tumor; cell organelle; mitochondrial dna; genetic identification; hepatocyte nuclear factor 1-beta |
| Journal Title: | Nature Communications |
| Volume: | 4 |
| ISSN: | 2041-1723 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2013-01-01 |
| Start Page: | 1628 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 23535649 |
| DOI: | 10.1038/ncomms2629 |
| PMCID: | PMC3848248 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 May 2013" - ":doi 10.1038/ncomms2629" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work